Cargando…

Empirical use of fluoroquinolones improves the survival of critically ill patients with tuberculosis mimicking severe pneumonia

INTRODUCTION: Empirical use of fluoroquinolones may delay the initiation of appropriate therapy for tuberculosis (TB). This study aimed to evaluate the impact of empirical fluoroquinolone use on the survival of patients with pulmonary TB that mimicked severe community-acquired pneumonia (CAP) requir...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tseng, Yu-Tzu, Chuang, Yu-Chung, Shu, Chin-Chung, Hung, Chien-Ching, Hsu, Chiung-Fang, Wang, Jann-Yuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3682311/ https://www.ncbi.nlm.nih.gov/pubmed/23098258 http://dx.doi.org/10.1186/cc11839

Ejemplares similares

Does empirical treatment of community-acquired pneumonia with fluoroquinolones delay tuberculosis treatment and result in fluoroquinolone resistance in Mycobacterium tuberculosis? Controversies and solutions
por: Shen, Gwan-Han, et al.
Publicado: (2012)

1495. Fluoroquinolone as an Alternative Regimen for Klebsiella pneumoniae Liver Abscess
por: Chuang, Chien, et al.
Publicado: (2019)

Tigecycline Therapy for Infections Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Critically Ill Patients
por: Yu, Wen-Liang, et al.
Publicado: (2020)

The impact of empiric antimicrobial therapy with a β-lactam and fluoroquinolone on mortality for patients hospitalized with severe pneumonia
por: Mortensen, Eric M, et al.
Publicado: (2006)

Fluoroquinolone-resistant Streptococcus pneumoniae
por: Pletz, Mathias W.R., et al.
Publicado: (2006)

Comparative Outcome Analysis of Penicillin-Based Versus Fluoroquinolone-Based Antibiotic Therapy for Community-Acquired Pneumonia: A Nationwide Population-Based Cohort Study
por: Wang, Chi-Chuan, et al.
Publicado: (2016)

Appropriate Treatment for Bloodstream Infections Due to Carbapenem-Resistant Klebsiella pneumoniae and Escherichia coli: A Nationwide Multicenter Study in Taiwan
por: Lin, Yi-Tsung, et al.
Publicado: (2018)

Does Antimicrobial Therapy Affect Mortality of Patients with Carbapenem-Resistant Klebsiella pneumoniae Bacteriuria? A Nationwide Multicenter Study in Taiwan
por: Chuang, Chien, et al.
Publicado: (2020)

Effectiveness of tigecycline-based versus colistin- based therapy for treatment of pneumonia caused by multidrug-resistant Acinetobacter baumannii in a critical setting: a matched cohort analysis
por: Chuang, Yu-Chung, et al.
Publicado: (2014)

The Role of Fluoroquinolones in the Treatment of Tuberculosis in 2019
por: Pranger, A. D., et al.
Publicado: (2019)

Asthma Therapies on Pulmonary Tuberculosis Pneumonia in Predominant Bronchiectasis–Asthma Combination
por: Yeh, Jun-Jun, et al.
Publicado: (2022)

Appropriateness of Empirical Fluoroquinolones Therapy in Patients Infected with Escherichia coli, Klebsiella pneumoniae, or Pseudomonas aeruginosa: The Importance of the CLSI Breakpoints Revision
por: Wang, Ying, et al.
Publicado: (2021)

Relative Fitness of Fluoroquinolone-resistant Streptococcus pneumoniae
por: Johnson, Crystal N., et al.
Publicado: (2005)

Improved Fluoroquinolone-Resistant and Extensively Drug-Resistant Tuberculosis Treatment Outcomes
por: Lee, Eun Hye, et al.
Publicado: (2019)

Clinical features of atypical tuberculosis mimicking bacterial pneumonia
por: Qi, Min, et al.
Publicado: (2021)

Patterns of Fluoroquinolone Prescribing at a Tuberculosis Hospital
por: Kizilbash, Quratulain, et al.
Publicado: (2017)

Fluoroquinolone resistance in multidrug-resistant tuberculosis patients
por: Lee, Hyun-Woo, et al.
Publicado: (2019)

Fluoroquinolone Derivatives in the Treatment of Mycobacterium tuberculosis Infection
por: Pais, João Pedro, et al.
Publicado: (2022)

2184. Effect of Adjusted CLSI Breakpoints on Center-wide Fluoroquinolone Susceptibilities for Enterobacteriaceae and Pseudomonas aeruginosa: Is It Time to Restrict Empiric Fluoroquinolone Use?
por: Sansom, Sarah, et al.
Publicado: (2019)

1459. Oral Cephalosporins vs. Fluoroquinolones for the Empiric Treatment of Acute Uncomplicated Pyelonephritis
por: Lin, Kevin, et al.
Publicado: (2019)

Fluoroquinolone Resistance in Clinical Isolates of Klebsiella Pneumonia e
por: Geetha, Pacha Venkataramana, et al.
Publicado: (2020)

Videofluoroscopy dysphagia severity scale is predictive of subsequent remote pneumonia in dysphagia patients
por: Huang, Poyin, et al.
Publicado: (2023)

Effects of acute critical illnesses on the performance of interferon-gamma release assay
por: Huang, Chun-Ta, et al.
Publicado: (2016)

Fluoroquinolone-Resistant Mycobacterium tuberculosis, Pakistan, 2005–2009
por: Jabeen, Kauser, et al.
Publicado: (2011)

The Use of Fluoroquinolones for Tuberculosis in Victoria between 2011 and 2016
por: Murray, Hugh, et al.
Publicado: (2018)

Cerebrospinal fluid concentrations of fluoroquinolones and carbapenems in tuberculosis meningitis
por: Maranchick, Nicole F., et al.
Publicado: (2022)

Prognostic Effects of Inappropriate Empirical Antimicrobial Therapy in Adults With Community-Onset Bacteremia: Age Matters
por: Hung, Yuan-Pin, et al.
Publicado: (2022)

Rituximab-induced pneumonitis mimicking miliary tuberculosis
por: Yao, Chih-Wei, et al.
Publicado: (2013)

Fluoroquinolone-resistant Salmonella sp. in Carcasses
por: Wang, Yu-Chih, et al.
Publicado: (2006)

Positive Association Between Fluoroquinolone Exposure and Tendon Disorders: A Nationwide Population-Based Cohort Study in Taiwan
por: Chang, Chun-Kai, et al.
Publicado: (2022)

Accelerated progression of pulmonary tuberculosis in a COVID-19 patient after corticosteroid treatment
por: Liu, Wang-Da, et al.
Publicado: (2022)

The incidence of collagen-associated adverse events in pediatric population with the use of fluoroquinolones: a nationwide cohort study in Taiwan
por: Yu, Pei-Han, et al.
Publicado: (2020)

Latent Tuberculosis Infection Increases in Kidney Transplantation Recipients Compared With Transplantation Candidates: A Neglected Perspective in Tuberculosis Control
por: Shu, Chin-Chung, et al.
Publicado: (2020)

Do fluoroquinolones actually increase mortality in community-acquired pneumonia?
por: Agarwal, Ritesh
Publicado: (2006)

Fluoroquinolone Resistance in Penicillin-resistant Streptococcus pneumoniae Clones, Spain
por: de la Campa, Adela G., et al.
Publicado: (2004)

Persistence and Complex Evolution of Fluoroquinolone-Resistant Streptococcus pneumoniae Clone
por: Ben-David, Debby, et al.
Publicado: (2014)

Timing of appropriate empirical antimicrobial administration and outcome of adults with community-onset bacteremia
por: Lee, Ching-Chi, et al.
Publicado: (2017)

Emergence of OXA-48-Producing Klebsiella pneumoniae in Taiwan
por: Ma, Ling, et al.
Publicado: (2015)

An empirical research on customer satisfaction study: a consideration of different levels of performance
por: Lee, Yu-Cheng, et al.
Publicado: (2016)

Fluoroquinolone and no risk of Achilles-tendinopathy in childhood pneumonia under eight years of age—a nationwide retrospective cohort
por: Kim, Yunsun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6adsrp8blruti67h0j4v6jt97l